跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25,935 条关于
“PD-L1 inhibitor”
全部
25,935
临床试验
13,824
药物
4,723
机构
26
资讯
7,362
2年前
FDA Approves Roche's Tecentriq Hybreza, a Subcutaneous PD-L1 Inhibitor, for Multiple Cancers
去年
Glenmark Initiates Global Phase 3 Trial for Subcutaneous PD-L1 Inhibitor Envafolimab in Stage III Lung Cancer
去年
OmRx Oncology Launches Phase 2 Trial of Novel Oral PD-L1 Inhibitor for NSCLC, Targeting Global Access Disparities
6个月前
ImmunoBrain Reports Phase 1b Results for Novel PD-L1 Checkpoint Inhibitor in Alzheimer's Disease
去年
Phase 3 Trials Advance PD-1/PD-L1 Inhibitors for BCG-Naive NMIBC
2年前
Adjuvant PD-1/PD-L1 Inhibitors Don't Improve Survival in Resectable NSCLC
去年
AI-Powered Molecular Subtyping Improves Prediction of Response to PD-L1 Inhibitors in Urothelial Carcinoma
去年
Study Shows No Added Benefit of Combining Chemotherapy with PD-1 Inhibitors in Second-Line NSCLC Treatment
去年
PD-1/PD-L1 Inhibitors Plus Chemotherapy Shows Improved Outcomes in Asian TNBC Patients
去年
PD-1/PD-L1 Inhibitors Show Promise in Thyroid Cancer Treatment Through Combination Strategies
第 1 页,共 737 页
上一页
下一页